The use of gonadotropin-releasing hormone antagonist in a flexible protocol: a pilot study
- 1 August 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 189 (2) , 444-446
- https://doi.org/10.1067/s0002-9378(03)00489-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- GnRH antagonist in assisted reproduction: a Cochrane reviewHuman Reproduction, 2002
- Gonadotropin-releasing hormone antagonist: how good is the new hope?Current Opinion in Obstetrics and Gynecology, 2001
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulationHuman Reproduction, 2001
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trialHuman Reproduction, 2000
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelinHuman Reproduction, 2000
- Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)Fertility and Sterility, 2000
- Cost-effectiveness of in vitro fertilizationPublished by Wolters Kluwer Health ,1999
- Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulationHuman Reproduction, 1994